Cargando…
Application of the adenosine triphosphate sensitivity assay in infantile vascular anomalies
BACKGROUND: The term vascular anomalies include various vascular tumors and vascular malformations, among them infantile hemangiomas and capillary malformations are the most well-known associated diseases in early ages. Multiple drugs have been introduced for intervention, but susceptibility test in...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7029611/ https://www.ncbi.nlm.nih.gov/pubmed/32075603 http://dx.doi.org/10.1186/s12887-020-1974-9 |
_version_ | 1783499206868074496 |
---|---|
author | Li, Li Yang, Bin Wei, Li Zhang, Bin Han, Xiao-feng Xu, Zi-gang Ma, Lin |
author_facet | Li, Li Yang, Bin Wei, Li Zhang, Bin Han, Xiao-feng Xu, Zi-gang Ma, Lin |
author_sort | Li, Li |
collection | PubMed |
description | BACKGROUND: The term vascular anomalies include various vascular tumors and vascular malformations, among them infantile hemangiomas and capillary malformations are the most well-known associated diseases in early ages. Multiple drugs have been introduced for intervention, but susceptibility test in vitro were scarcely reported. OBJECTIVE: To evaluate the inhibition effect of different drugs by adenosine triphosphate sensitivity assay in vitro before the treatment of infantile hemangiomas and capillary malformations. METHODS: Specimens were selected from 5 cases of infantile hemangiomas and 11 cases of capillary malformations. Propranolol, rapamycin, sildenafil and itraconazole were tested for their growth inhibition effect by using the adenosine triphosphate sensitivity assay. RESULTS: Propranolol demonstrated inhibitory effects on infantile hemangiomas cells. Rapamycin and itraconazole both showed inhibitory effects on infantile hemangiomas cells and capillary malformations cells. Sildenafil has no growth inhibitory effect on infantile hemangiomas cells or capillary malformations cells. CONCLUSION: Adenosine triphosphate sensitivity assay is a sensitive and useful testing method before the management of vascular anomalies, and individualized medication suggestions for the choice of therapeutic drugs were offered based on the testing result and together with a comprehensive evaluation of each infant. |
format | Online Article Text |
id | pubmed-7029611 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-70296112020-02-25 Application of the adenosine triphosphate sensitivity assay in infantile vascular anomalies Li, Li Yang, Bin Wei, Li Zhang, Bin Han, Xiao-feng Xu, Zi-gang Ma, Lin BMC Pediatr Research Article BACKGROUND: The term vascular anomalies include various vascular tumors and vascular malformations, among them infantile hemangiomas and capillary malformations are the most well-known associated diseases in early ages. Multiple drugs have been introduced for intervention, but susceptibility test in vitro were scarcely reported. OBJECTIVE: To evaluate the inhibition effect of different drugs by adenosine triphosphate sensitivity assay in vitro before the treatment of infantile hemangiomas and capillary malformations. METHODS: Specimens were selected from 5 cases of infantile hemangiomas and 11 cases of capillary malformations. Propranolol, rapamycin, sildenafil and itraconazole were tested for their growth inhibition effect by using the adenosine triphosphate sensitivity assay. RESULTS: Propranolol demonstrated inhibitory effects on infantile hemangiomas cells. Rapamycin and itraconazole both showed inhibitory effects on infantile hemangiomas cells and capillary malformations cells. Sildenafil has no growth inhibitory effect on infantile hemangiomas cells or capillary malformations cells. CONCLUSION: Adenosine triphosphate sensitivity assay is a sensitive and useful testing method before the management of vascular anomalies, and individualized medication suggestions for the choice of therapeutic drugs were offered based on the testing result and together with a comprehensive evaluation of each infant. BioMed Central 2020-02-19 /pmc/articles/PMC7029611/ /pubmed/32075603 http://dx.doi.org/10.1186/s12887-020-1974-9 Text en © The Author(s). 2020 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Research Article Li, Li Yang, Bin Wei, Li Zhang, Bin Han, Xiao-feng Xu, Zi-gang Ma, Lin Application of the adenosine triphosphate sensitivity assay in infantile vascular anomalies |
title | Application of the adenosine triphosphate sensitivity assay in infantile vascular anomalies |
title_full | Application of the adenosine triphosphate sensitivity assay in infantile vascular anomalies |
title_fullStr | Application of the adenosine triphosphate sensitivity assay in infantile vascular anomalies |
title_full_unstemmed | Application of the adenosine triphosphate sensitivity assay in infantile vascular anomalies |
title_short | Application of the adenosine triphosphate sensitivity assay in infantile vascular anomalies |
title_sort | application of the adenosine triphosphate sensitivity assay in infantile vascular anomalies |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7029611/ https://www.ncbi.nlm.nih.gov/pubmed/32075603 http://dx.doi.org/10.1186/s12887-020-1974-9 |
work_keys_str_mv | AT lili applicationoftheadenosinetriphosphatesensitivityassayininfantilevascularanomalies AT yangbin applicationoftheadenosinetriphosphatesensitivityassayininfantilevascularanomalies AT weili applicationoftheadenosinetriphosphatesensitivityassayininfantilevascularanomalies AT zhangbin applicationoftheadenosinetriphosphatesensitivityassayininfantilevascularanomalies AT hanxiaofeng applicationoftheadenosinetriphosphatesensitivityassayininfantilevascularanomalies AT xuzigang applicationoftheadenosinetriphosphatesensitivityassayininfantilevascularanomalies AT malin applicationoftheadenosinetriphosphatesensitivityassayininfantilevascularanomalies |